Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2025-12-26 @ 4:11 AM
Study NCT ID:
NCT00049127
Status:
COMPLETED
Last Update Posted:
2019-10-21
First Post:
2002-11-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
ACTUAL
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2002-11-12
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-11-25
Results First Submit QC Date:
None
Results First Post Date:
2014-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-04
Last Update Post Date:
2019-10-21
Last Update Post Date Type:
ACTUAL